Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy - PubMed (original) (raw)
- PMID: 16037
- PMCID: PMC372286
- DOI: 10.1172/JCI108700
Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy
J D Conger et al. J Clin Invest. 1977 May.
Abstract
Tubular fluid flow, urine osmolality, and pH were selectively altered to determine the relative protective roles of these factors in a rat model of acute urate nephrophathy. Various prehyper uricemic conditions were established in five groups of animals: (a) normopenic Wistar rats given no pretreatment (Group I); (b) Wistar rats given acetazolamide, 20 mg/kg, and isotonic NaHCO3 to produce urine alkalinization (Group II); (c) Wistar rats in which a moderate diuresis, similar to that observed in Group II but without urine alkalinization, was induced with furosemide, 2 mg/kg (Group III); (d) Wistar rats in which a high-flow solute diuresis was induced with furosemide, 15 mg/kg (Group IV); (e) Brattleboro rats, homozygous for pituitary diabetes insipidus, that had a spontaneous high-flow water diuresis (Group V). A comparable level of hyperuricemia (19.4+/-2.2 mg/100 ml) was achieved in all animals with intravenous urate infusion. Clearance and micropuncture studies were performed before and 1 h after induction of hyperuicemia. Group I rats had mean falls in renal plasma flow and glomerular filtration rate of 83 and 86%, respectively; nephron filtration rate decreased 66%, and tubular and microvascular pressures increased twofold. In Group II there were 45 and 47% declines in renal plasma flow and glomerular filtration rate, respectively, a 66% fall in nephron filtration rate, and a 30% increase in tubular and vascular pressures. Moderate amounts of urate were seen in the kidneys. Group III had changes in renal function identical to Group II suggesting that the moderate prehyperuricemic diuresis in the latter group and not urine alkalinization produced the partial protection observed. Groups IV and V were completely and comparably protected with renal function studies unchanged from controls. It is concluded that high tubular fluid flow, whether induced by a solute or water diuresis, is the primary mechanism of protection in acute urate nephropathy. At most, urine alkalinization plays a minor preventive role.
Similar articles
- A micropuncture study of the early phase of acute urate nephropathy.
Conger JD, Falk SA, Guggenheim SJ, Burke TJ. Conger JD, et al. J Clin Invest. 1976 Sep;58(3):681-9. doi: 10.1172/JCI108514. J Clin Invest. 1976. PMID: 956394 Free PMC article. - Effects of acute unilateral renal denervation in the rat.
Bello-Reuss E, Colindres RE, Pastoriza-Muñoz E, Mueller RA, Gottschalk CW. Bello-Reuss E, et al. J Clin Invest. 1975 Jul;56(1):208-17. doi: 10.1172/JCI108069. J Clin Invest. 1975. PMID: 1141432 Free PMC article. - Influence of renal nerves and sodium balance on the acute antidiuretic effect of bendroflumethiazide in rats with diabetes insipidus.
Spannow J, Thomsen K, Petersen JS, Haugan K, Christensen S. Spannow J, et al. J Pharmacol Exp Ther. 1997 Sep;282(3):1155-62. J Pharmacol Exp Ther. 1997. PMID: 9316821 - Renal function tests in experimental toxicity studies.
Diézi J, Biollaz J. Diézi J, et al. Pharmacol Ther B. 1979;5(1-3):135-45. doi: 10.1016/0163-7258(79)90081-0. Pharmacol Ther B. 1979. PMID: 40261 Review. No abstract available. - Contrast-induced kidney injury: mechanisms, risk factors, and prevention.
Seeliger E, Sendeski M, Rihal CS, Persson PB. Seeliger E, et al. Eur Heart J. 2012 Aug;33(16):2007-15. doi: 10.1093/eurheartj/ehr494. Epub 2012 Jan 19. Eur Heart J. 2012. PMID: 22267241 Review.
Cited by
- Relapse of Lung Adenocarcinoma Manifested by Spontaneous Tumor Lysis Syndrome.
Im D, Alsheimer K, Poulose J, Zeykan V, Talamo G. Im D, et al. Case Rep Oncol. 2023 Nov 6;16(1):1306-1310. doi: 10.1159/000534398. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37942403 Free PMC article. - Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology.
Lupușoru G, Ailincăi I, Frățilă G, Ungureanu O, Andronesi A, Lupușoru M, Banu M, Văcăroiu I, Dina C, Sinescu I. Lupușoru G, et al. Biomedicines. 2022 Apr 28;10(5):1012. doi: 10.3390/biomedicines10051012. Biomedicines. 2022. PMID: 35625753 Free PMC article. Review. - Clinical Interventions to Prevent Tumour Lysis Syndrome in Hematologic Malignancy: A Multisite Retrospective Chart Review.
McKenna S, Cheung A, Wolfe A, Coleman BL, Detsky ME, Munshi L, Maze D, Burry L. McKenna S, et al. Can J Hosp Pharm. 2019 Nov-Dec;72(6):435-445. Epub 2019 Dec 1. Can J Hosp Pharm. 2019. PMID: 31853144 Free PMC article. - Understanding tumor lysis syndrome.
Zafrani L, Canet E, Darmon M. Zafrani L, et al. Intensive Care Med. 2019 Nov;45(11):1608-1611. doi: 10.1007/s00134-019-05768-x. Epub 2019 Sep 13. Intensive Care Med. 2019. PMID: 31520104 No abstract available. - Hyperuricemia complicated with acute kidney injury is associated with adverse outcomes in patients with severely decompensated acute heart failure.
Shirakabe A, Okazaki H, Matsushita M, Shibata Y, Goda H, Uchiyama S, Tani K, Kiuchi K, Kobayashi N, Hata N, Asai K, Shimizu W. Shirakabe A, et al. Int J Cardiol Heart Vasc. 2019 Mar 21;23:100345. doi: 10.1016/j.ijcha.2019.03.005. eCollection 2019 Jun. Int J Cardiol Heart Vasc. 2019. PMID: 31321285 Free PMC article.
References
- J Clin Invest. 1975 Feb;55(2):283-91 - PubMed
- Am J Dis Child. 1975 Aug;129(8):956-8 - PubMed
- Kidney Int. 1975 Nov;8(5):334-7 - PubMed
- Am J Med. 1958 Oct;25(4):532-8 - PubMed
- J Chronic Dis. 1963 Jul;16:757-76 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources